SciELO - Scientific Electronic Library Online

vol.136 issue10Gastric adenocarcinoma appearing 32 years after the resection of a gastric lymphoma. Report of one caseRole of cytochrome P450 enzymes in the metabolism of antineoplastic drugs author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista médica de Chile

Print version ISSN 0034-9887


SAJAMA, Carlos; LORENZONI, José  and  TAGLE, Patricio. Diagnosis and treatment of brain metastasis. Rev. méd. Chile [online]. 2008, vol.136, n.10, pp.1321-1326. ISSN 0034-9887.

Cerebral metastasis occur in 20 to 30 percent of patients with systemic cancer and are the most common type of intracranial tumor. The median survival of untreated patients is one month with a slightly longer survival in those treated with steroids. Patients treated with whole brain radiation therapy survive between 3 to 6 months. In selected cases survival can increase to 10 to 12 months with combination of surgery and radiotherapy or stereotactic radiosurgery alone or associated to radiotherapy. Most brain metástasis arise from lung, breast and melanomas. The most important criteria for selecting patients who will benefit from surgery or stereotactic radiosurgery are a Karnofsky score of 70 or more, systemic control of the cancer and absence of leptomeningeal involvement. Surgery is indicated in patients with a single lesion located in an accessible zone and stereotactic radiosurgery is indicated for lesions up to 3 cm of diameter, and in patients with up to 3 or 4 metastasis, no matter their location. The survival benefit of chemotherapy in brain metastasis has not been demonstrated.

Keywords : Brain neoplasm; Cranial irradiation; Neoplasm metastasis; Radiosurgery.

        · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License